Curable. Inc. (XKON:086460)

Market Cap	n/a
Revenue (ttm)	2.42B
Net Income (ttm)	347.47M
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,530
Average Volume	4,230
Open	80.00
Previous Close	n/a
Day's Range	35.00 - 80.00
52-Week Range	35.00 - 99,000.00
Beta	0.26
RSI	29.84
Earnings Date	n/a

About Curable.

Curable. Inc. provides single nucleotide polymorphism (SNP) research and analysis services in South Korea. The company offers various services, such as genome analyzer; and sequencing and re-sequencing, immunoprecipitate sequencing, small RNA discovery and analysis, and digital gene expression profiling services. It also provides SNP genotyping services; SNP discovery services; and microsatellites typing, DNA sequencing, bio-informatics, gene identification, and statistical analysis services. The company serves pharmaceutical companies. The com...

• Industry: Commercial Physical and Biological Research
• Founded: 2000
• Employees: 16
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 086460

Financial Performance

In 2012, Curable.'s revenue was 2.42 billion, an increase of 5.62% compared to the previous year's 2.29 billion. Earnings were 347.47 million, a decrease of -24.85%.